about
Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cellsTRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoproteinmiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatmentIQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cellsIntegrated proteomic and metabolic analysis of breast cancer progressionCD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesisInferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer.Human RAS superfamily proteins and related GTPases.Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cellsThree-dimensional overlay culture models of human breast cancer reveal a critical sensitivity to mitogen-activated protein kinase kinase inhibitors.Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.Discovery and characterization of inhibitors of human palmitoyl acyltransferases.Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells.Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogeneThe HER family and cancer: emerging molecular mechanisms and therapeutic targets.Post-transcriptional regulation of connexin43 in H-Ras-transformed cellsA positive feedback loop couples Ras activation and CD44 alternative splicingSelumetinib produces a central core of apoptosis in breast cancer bone metastases in miceDominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness.Induction of Ras by SAF-1/MAZ through a feed-forward loop promotes angiogenesis in breast cancer.A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signalingIsoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesisEpidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancerUpdate on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studiesAltered glucose metabolism in Harvey-ras transformed MCF10A cellsCell type of origin as well as genetic alterations contribute to breast cancer phenotypesp53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.Phospho-specific Smad3 signaling: impact on breast oncogenesis.p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasionModelling cancer in human skin tissue.Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response.
P2860
Q24293321-CF674AF1-D413-4850-ACFB-F47E05D5E723Q24308021-94FC2F1F-54AF-4907-A505-43162B2B3F65Q24613599-865A1B49-7A9A-4C9C-BF2F-0D4EE2B3729DQ26782585-C4A59606-8712-4739-AA08-0334679A04E8Q28256129-9A0C6782-40AF-49C3-91D3-9DB303933ED1Q28533861-C5F06FFC-F088-4752-A8B2-D75B638E6005Q30431290-B2004227-2090-4C80-8C46-0219B24CB13BQ30440746-D1FAACB8-9E20-4336-9E0B-38C80A0C07C2Q33601436-1FDD02E9-1025-4365-A90C-AF853DD8C2C6Q33605369-CABEC756-F203-4D46-9642-AF5CB3FD64B4Q33618363-B02B5091-FA85-4774-A143-4DB9A6966BF9Q33635061-823B8306-F811-4D0F-85C1-17279EB05305Q33689727-33A70516-BAA7-4743-A2A2-E3128574BB0CQ33705623-980EF2EE-1B1D-47B8-9F92-080602F089ECQ33714946-A57CB7FC-EAAE-4692-96CA-996E1FEBB190Q33739233-A0E60C2B-5E7C-466E-8488-FA5474EA9E1FQ33837060-A824FBD5-2D1D-4661-8C4F-7F2DBCEE3187Q33923711-B0F6897F-245C-4605-9DFA-5C22D35D596DQ34048220-74806472-D03A-4076-A711-61A12E0DD064Q34125310-DCB0A0F0-B4FA-4786-B2E7-BA532CF7E68AQ34283602-2CD705EF-51D5-46BC-9D31-EE2B8FF27FA0Q34305782-32E046BD-1922-44DC-AF90-CE89C1F1B6A0Q34558080-9A13757C-31B2-4EFA-A103-5401B1AF161AQ34625872-F488FD14-0A75-4BFD-B8AE-2048C530974EQ34863324-BC1DDBC0-E902-407E-8F91-80B050A7684BQ35004008-6FAE7779-C25A-491A-947C-5349BC46768FQ35062069-4CC7F64E-FDE5-4068-82A5-82E04CDE6D61Q35070726-32030103-8BD8-4657-B72D-097B17A13869Q35084925-564FBFF1-4E73-4BEF-8A54-B0D11403F3D7Q35106366-AEC1C78A-06A5-49EE-AD12-0E6B3C18B153Q35131418-4B9DEA9B-8BBD-4A2E-A9A1-F20B398F2A71Q35134513-FCDBB347-BF52-4D4B-8C82-B4A79B401542Q35573116-715C7C44-65C4-4C2A-AF2A-B481E40DCB7BQ35742791-CB0C26B6-39FE-43AA-B5AB-A68B6F834882Q35832288-396E59C7-5155-41E7-9534-5ECFF35825C4Q36107330-E2BDCD13-712B-4F44-9CF5-739370664271Q36116217-0759B7F2-A594-4CA5-954E-FB1E4D52B28DQ36326219-30887AFA-924A-4826-9209-67A447DA753FQ36422870-73B16402-4BB9-47D1-98EB-CC7E0C240F39Q36535582-9DCC16E2-A4EE-42C3-BD85-33AF7B372B84
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Ras activation in human breast cancer.
@en
Ras activation in human breast cancer.
@nl
type
label
Ras activation in human breast cancer.
@en
Ras activation in human breast cancer.
@nl
prefLabel
Ras activation in human breast cancer.
@en
Ras activation in human breast cancer.
@nl
P2093
P2860
P356
P1476
Ras activation in human breast cancer.
@en
P2093
Casteel DE
Dreilinger AD
Wallace AM
von Lintig FC
P2860
P2888
P356
10.1023/A:1006491619920
P407
P577
2000-07-01T00:00:00Z
P6179
1000747306